@article{8bb0512d212a4e65a7cfddc3ef2f18f5,
title = "The Nucleosome Remodelling and Deacetylation complex suppresses transcriptional noise during lineage commitment",
abstract = "Multiprotein chromatin remodelling complexes show remarkable conservation of function amongst metazoans, even though components present in invertebrates are often found as multiple paralogous proteins in vertebrate complexes. In some cases, these paralogues specify distinct biochemical and/or functional activities in vertebrate cells. Here, we set out to define the biochemical and functional diversity encoded by one such group of proteins within the mammalian Nucleosome Remodelling and Deacetylation (NuRD) complex: Mta1, Mta2 and Mta3. We find that, in contrast to what has been described in somatic cells, MTA proteins are not mutually exclusive within embryonic stem (ES) cell NuRD and, despite subtle differences in chromatin binding and biochemical interactions, serve largely redundant functions. ES cells lacking all three MTA proteins exhibit complete NuRD loss of function and are viable, allowing us to identify a previously unreported function for NuRD in reducing transcriptional noise, which is essential for maintaining a proper differentiation trajectory during early stages of lineage commitment.",
keywords = "ES Cell, NuRD, chromatin, lineage commitment, transcription",
author = "Thomas Burgold and Michael Barber and Susan Kloet and Julie Cramard and Sarah Gharbi and Robin Floyd and Masaki Kinoshita and Meryem Ralser and Michiel Vermeulen and Nicola Reynolds and Sabine Dietmann and Brian Hendrich",
note = "Funding Information: We thank Bill Mansfield, Peter Humphreys, Maike Paramor, Vicki Murray and Sally Lees for technical assistance and advice, and Alexander Brehm, Austin Smith, Ernest Laue and members of the BDH laboratory for discussions and comments on the manuscript. Funding to the BH and MV laboratories was provided through EU FP7 Integrated Project “4DCellFate” (277899). The BH laboratory further benefitted from a Wellcome Trust Senior Fellowship (098021/Z/11/Z) and from core funding to the Cambridge Stem Cell Institute from the Wellcome Trust and Medical Research Council (097922/Z/11/Z and 203151/Z/16/Z). The Vermeulen laboratory is part of the Oncode Institute, which is partly funded by the Dutch Cancer Society (KWF). Funding Information: We thank Bill Mansfield, Peter Humphreys, Maike Paramor, Vicki Murray and Sally Lees for technical assistance and advice, and Alexander Brehm, Austin Smith, Ernest Laue and members of the BDH laboratory for discussions and comments on the manuscript. Funding to the BH and MV laboratories was provided through EU FP7 Integrated Project ?4DCellFate? (277899). The BH laboratory further benefitted from a Wellcome Trust Senior Fellowship (098021/Z/11/Z) and from core funding to the Cambridge Stem Cell Institute from the Wellcome Trust and Medical Research Council (097922/Z/11/Z and 203151/Z/16/Z). The Vermeulen laboratory is part of the Oncode Institute, which is partly funded by the Dutch Cancer Society (KWF). Publisher Copyright: {\textcopyright} 2019 The Authors. Published under the terms of the CC BY 4.0 license",
year = "2019",
month = jun,
day = "17",
doi = "10.15252/embj.2018100788",
language = "English",
volume = "38",
journal = "EMBO Journal",
issn = "0261-4189",
number = "12",
}